Pharmawatch Articles
Vedolizumab – New Drug May Offer Hope To Patients Of Inflammatory Bowel Disease
Vedolizumab, a new drug, initially developed by Millennium Pharmaceuticals that was taken over by Takeda Pharmaceuticals, is a monoclonal antibody, and has been under trial for use in ulcerative colitis (UC) and Crohn’s disease (CD), that are part of Inflammatory Bowel Disease (IBD) This antibody has been found to be more effective than a placebo [...]
Bayer’s Nexavar May Get FDA Approval for Thyroid Cancer
Nexavar (Sorafenib) is drug that is manufactured by Bayer and is used to treat renal cell cancer and Hepatocellular carcinoma (HCC). Depending on the individual patient and his or her medical history situation, the drug is prescribed for kidney and liver cancer and helps slow the growth and progression of the cancer. Latest research that [...]
Is making profits risking your health?
At least once per day if not more you will see on your television screen a class action lawsuit for some drug asking you to call this attorney if you have taken this drug, that drug, or used this medical product. What goes on behind the closed doors of the Big Pharmaceutical companies, the researchers, [...]
Lorcaserin or Lorqess: Analysis of FDA Panel
This is an analysis of Lorcaserin or Lorqess and the upcoming FDA advisory panel. If curious or have any questions or want more such analysis, please email [email protected] – thanks! Lorcaserin or Lorqess is going up for an FDA advisory panel on September 16, 2010. It is an obesity drug that has generated a lot [...]
Analysis: Probability of Acthar Approval
This is selected excerpts from an analysis Health and Life published for the pharmaceutical industry. If interested in receiving similar reports for future drug approvals, email [email protected] Thank you. Who: Questcor (QCOR: $10.02) is a small pharmaceutical company seeking an expanded indication for its treatment Acthar. Acthar is currently mainly used in multiple sclerosis and [...]
Obesity Drugs 2010, Which Is the Best?
Three weight-loss pills are going up for FDA approval this year, 2010 – Qnexa, lorcaserin, and Contrave. Here we present the state of the field for weight-loss pills and analyze each treatment. Currently, there are not that many treatments for obesity right now in terms of medication. The main three that are commonly used now [...]
Vyvanse: Many Advantages as ADHD Therapy?
Vyvanse is a new treatment for ADHD that is very promising. Importantly, it has several advantages that distinguish it from the many competing treatments. At Health and Life, we are skeptical by nature, but there are advantages to Vyvanse that make it stand out. In our analysis, Vyvanse tends to provide consistent and effective treatment [...]
The New Medications in 2010 – Highlights
As someone who spends a fair bit of time thinking about and dealing with medications and treatments, I like to think I know a little about the subject. And, to be honest, I was getting a little concerned. It seemed like there was a real lack of innovative therapies coming to market. Conducting analysis of [...]
Qnexa for Weight Loss; Side Effects
Qnexa is a new medication that will go for FDA approval in 2010 and is a treatment for obesity. It consists of phentermine and topiramate and has shown excellent results in studies to date. Concerns, however, remain about its safety and long run effectiveness. Medications to help people lose weight have had a rocky history. [...]
The Weekly Pharma News Update #6
It's Sunday - and that means another Weekly Pharma News Update from Health and Life. What were the most interesting and important news items of the last week regarding the biopharmaceutical industry? #1 Nobel Prize-winning scientist Sir James Black dies We were deeply saddened by the tragic news of Sir James Black’s passing. He is [...]
Latest Comments